Whether PRDX4 hyperoxidation in diabetes models is due to excess ERO1β activity is not known, but as discussed earlier, ERO1β overexpression promotes ER hyperoxidation, which consequently leads to inactivation of PRDX4 [40]. Here, ERO1B is linked to diabetes mellitus.